Amedisys (NASDAQ:AMED - Get Free Report)'s stock had its "equal weight" rating reissued by stock analysts at Stephens in a research report issued on Wednesday,Benzinga reports. They presently have a $101.00 price objective on the health services provider's stock. Stephens' price target would suggest a potential upside of 9.07% from the stock's current price.
Amedisys Stock Down 0.2 %
Shares of AMED stock traded down $0.18 on Wednesday, hitting $92.60. The stock had a trading volume of 130,693 shares, compared to its average volume of 266,508. Amedisys has a 52-week low of $82.15 and a 52-week high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a market capitalization of $3.03 billion, a price-to-earnings ratio of 36.75, a P/E/G ratio of 1.82 and a beta of 0.73. The stock's 50 day moving average is $90.11 and its 200-day moving average is $93.61.
Hedge Funds Weigh In On Amedisys
A number of institutional investors have recently modified their holdings of AMED. Blue Trust Inc. grew its holdings in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the last quarter. Xponance Inc. boosted its position in shares of Amedisys by 3.5% in the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock valued at $395,000 after acquiring an additional 148 shares during the period. Inspire Investing LLC raised its stake in Amedisys by 3.6% in the fourth quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock valued at $400,000 after purchasing an additional 155 shares in the last quarter. Gamco Investors INC. ET AL raised its stake in Amedisys by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after acquiring an additional 159 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Amedisys by 1.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock valued at $1,375,000 after buying an additional 180 shares during the period. Institutional investors own 94.36% of the company's stock.
About Amedisys
(
Get Free Report)
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
See Also
Before you consider Amedisys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amedisys wasn't on the list.
While Amedisys currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
